Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00011141 · ClinicalTrials.gov registry record · NA
Lactobacillus Plantarum as Therapy for NK-T Cell Deficiency
A NA study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- NA
- Development phase
NCT00011141: Completed NA study, sponsored by National Center for Research Resources (NCRR).
NCT00011141 is a NA study that has completed, run by National Center for Research Resources (NCRR). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00011141, a NA study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The etiology of immune-mediated diabetes mellitus (IMD) remains unclear. However, previous studies indicate that autoimmunity may be a result of dysfunction of natural killer T cells (NK-T cells). Newly diagnoses patients with IMD have been shown in our laboratory to have significantly lower NK-T cells than normal controls. Other studies have shown that oral administration of lactobacillus can boost NK-T cell activity in children with HIV without side effects. Our objective is to evaluate the effect of lactobacillus administration on NK-T cell activity in patients with IMD
Interventions
- DRUG Oral lactobacillus administration
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00011141 record still lists
NCT00011141 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Oral lactobacillus administration is the first listed.
NCT00011141 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00011141 about?
NCT00011141 is a clinical study titled "Lactobacillus Plantarum as Therapy for NK-T Cell Deficiency". The etiology of immune-mediated diabetes mellitus (IMD) remains unclear. However, previous studies indicate that autoimmunity may be a result of dysfunction of natural killer T cells (NK-T cells). Newly diagnoses patients with IMD have been shown in our laboratory to have significantly lower NK-T ce...
What is the current status of trial NCT00011141?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00011141?
The interventions under investigation include: Oral lactobacillus administration (DRUG).
Who is sponsoring clinical trial NCT00011141?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.